Segment Information - Segment Revenue, Operating Loss and Depreciation and Amortization (Detail) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Revenue	$ 24,933	$ 23,003
Total operating (loss) income	(7,229)	(3,441)
Depreciation and amortization	2,122	2,376
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	24,933	23,003
Total operating (loss) income	(4,287)	637
Operating Segments [Member] | Medical Device [Member]
Segment Reporting Information [Line Items]
Revenue	19,018	16,908
Total operating (loss) income	(7,235)	(3,792)
Depreciation and amortization	1,953	2,194
Operating Segments [Member] | In Vitro Diagnostics [Member]
Segment Reporting Information [Line Items]
Revenue	5,915	6,095
Total operating (loss) income	2,948	3,155
Depreciation and amortization	77	86
Corporate Non Segment [Member]
Segment Reporting Information [Line Items]
Total operating (loss) income	(2,942)	(2,804)
Depreciation and amortization	$ 92	$ 96